Literature DB >> 7737282

The protein defective in X-linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross-linked.

S Hinshelwood1, R C Lovering, H C Genevier, R J Levinsky, C Kinnon.   

Abstract

X-linked agammaglobulinemia is a primary inherited immunodeficiency resulting in a lack of or dramatic reduction in the number of mature B lymphocytes and, thus, greatly reduced levels of serum immunoglobulin. The defect results from mutations in the gene for Bruton's tyrosine kinase (Btk). Using rabbit antisera generated against Btk, we have demonstrated an increase in the level of in vitro kinase activity present in anti-Btk immunoprecipitates from B cells following stimulation with anti-immunoglobulin antibody. This increase in immune complex kinase activity is detectable 1 to 2 min following stimulation and remains elevated for over 30 min. A similar increase was not seen with two late pre-B cell lines investigated in the same way. This stimulation of activity may suggest a role for Btk in signalling through the B cell receptor or associated proteins, in mature B cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737282     DOI: 10.1002/eji.1830250439

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Authors:  M I Wahl; A C Fluckiger; R M Kato; H Park; O N Witte; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.

Authors:  H B Gaspar; T Lester; R J Levinsky; C Kinnon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.

Authors:  C D Novina; S Kumar; U Bajpai; V Cheriyath; K Zhang; S Pillai; H H Wortis; A L Roy
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

4.  A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2.

Authors:  M Takata; T Kurosaki
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

5.  The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase.

Authors:  G O Cory; R C Lovering; S Hinshelwood; L MacCarthy-Morrogh; R J Levinsky; C Kinnon
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.